Effect of phosphodiesterase III inhibitor on plasma concentrations of endothelin-1 and tumour necrosis factor in patients with acute heart failure

Acta Cardiologica

Volumn 57, Issue 1, 2002, Pages 19-21

  Nakamura, Tsukasa ^a   Suzuki, Shingo ^a   Ushiyama, Chifuyu ^a   Shimada, Noriaki ^a   Koide, Hikaru ^a  

^a KOTO HOSPITAL   (Japan)

Author keywords

Endothelin; Heart failure; Inotropic agent; Phosphodiesterase

Indexed keywords

ENDOTHELIN 1; LOPRINONE; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART OUTPUT; HEMODYNAMICS; HUMAN; INOTROPISM; MALE; PATHOPHYSIOLOGY;

EID: 0036486868     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.57.1.2005374     Document Type: Article

References (20)

1. Monrad ES, Baim DS, Smith HS, Lanone AS, Braunwald E, Grossman W. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 1985; 71: 972-9.
2. Silver PJ. Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase. Am J Cardiol 1989; 63: 2A-8A.
3. Tanio H, Kumada T, Hayashi M, Himura Y, Nakamura Y, Kawai C. Hemodynamic efficacy of E-1020 in comparison with dopamine on acute mitral regurgitation in anesthetized dogs. Jpn Circ J 1991; 55: 1068-76.
4. Kimata S, Hirosawa K, Kananuki H, Takano T, Serizawa T, Sasayama S, Kumada T, Hori M, Hiramori K. Clinical effects of E-1020 on acute heart failure: evaluation of acute hemodynamic effects of bolus injection and continuous infusion. Jpn J Clin Exp Med 1992; 69: 2260-74.
5. Galatius-Jensen S, Wroblewski H, Emmeluth C, Bie P, Haunso S, Kastrup J. Plasma endothelin in congestive heart failure: a predictor of cardiac death? J Card Fail 1996; 2: 71-76.
6. Pousset F, Isnard R, Lechat P, Kalotka H, Caravon A, Maistre G, Escolano S, Thomas D, Komajda M. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 1997; 18: 254-8.
7. Matsumori A. The use of cytokine inhibitors. A new therapeutic insight into heart failure. Int J Cardiol 1997; 62: Suppl 11: S3-S12.
8. Ebihara I, Nakamura T, Takahashi T, Tomino Y, Shimada N, Koide H. Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients. Perit Dial Int 1997; 17: 595-601.
9. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor-α. Kidney Int 1990; 37: 116-25.
10. Murakami R, Sano K, Murakami Y, Shimada T, Morishita S. Effects of intracoronary infusion of an inotropic agent, loprinone hydrochloride, on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship. Int J Cardiol. 1995; 51: 57-63.
11. Takaoka H, Takeuchi M, Odake M. Comparison of the effects on arterial-ventricular coupling between phosphodiesterase inhibitor and dobutamine in the diseased human heart. J Am Coll Cardiol 1993; 22: 598-606.
12. Yamaura K, Akiyoshi K, Irita K, Taniyama T, Takahashi S. Effects of olprinone, a new phosphodiesterase inhibitor, on gastric intramucosal acidosis and systemic inflammatory responses following hypothermic cardiopulmonary bypass. Acta Anaesthesiol Scand 2001; 45: 427-34.
13. Tukiiri K, Mizushige K, Ueda T, Nishiyama Y, Aoyama T, Kohno M. Effects of olprinone, a phosphodiesterase 3 inhibitor, on regional cerebral blood flow of cerebral cortex in stroke patients. J Cardiovasc Pharmacol 2001; 37: 375-80.
14. Love MP, McMurray JJV. Endothelin in congestive heart failure. Basic Res Cardiol 1996; 91: 21-9.
15. Haynes WG, Webb DJ. The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci 1993; 84: 485-500.
16. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol 1992; 262: C854-61.
17. Cybulsky AV, Stewart DJ, Cybulsky MI. Glomerular epithelial cells produce endothelin-1. J Am Soc Nephrol 1993; 3: 1398-1404.
18. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1993; 323: 236-41.
19. Doyama K, Fujiwara H, Fukumoto M, Tanaka M, Fujiwara Y, Oda T, Ohtani S, Hasegawa K, Fujiwara T, Sasayama S. Tumor necrosis factor is expressed in cardiac tissues of patients with heart failure. Int J Cardiol 1996; 54: 217-75.
20. Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S. Differential modulation of cytokine production by drugs: implications for therapy in heart failure. J Mol Cell Cardiol 1996; 28: 2491-99.